Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
NCT ID: NCT01569698
Last Updated: 2021-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
310 participants
OBSERVATIONAL
2012-06-30
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the absence of clear standard of care, the choice of the extra renal replacement therapy modality is subject to clinical judgement, practical aspects, and costs.
This study will supply important data about usual modalities of pediatric acute extra renal replacement therapy and their impact on patient outcome and renal recovery. An obvious next step will be to conduct a randomized controlled trial comparing the different strategies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
More Frequent In-Center Hemodialysis in Pediatric End Stage Renal Disease
NCT01352455
Dialysis Weaning in Intensive Care Units (Dialysis STOP)
NCT03763188
Safety and Performance Evaluation of multiPlus Dialysate During CRRT
NCT05315817
Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
NCT01327391
Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA
NCT04462614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will supply important data about pediatric acute extra renal replacement therapy, including the epidemiology of pediatric acute kidney injury leading to extra renal replacement therapy, the variety of the treatment modalities, and their effects on the course of the disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
extrarenal replacement therapy
Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis
acute extra renal replacement therapy
usual modalities of pediatric acute extra renal replacement therapy : Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acute extra renal replacement therapy
usual modalities of pediatric acute extra renal replacement therapy : Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute kidney injury as defined by pRIFLE classification requiring extra renal replacement therapy, whatever is the method.
Exclusion Criteria
* History of renal transplantation;
* Extra renal replacement therapy for an inborn errors of metabolism without acute renal failure;
* Extra renal replacement therapy in the context of a drug intoxication without acute renal failure;
* Treatment by technique in MARS (Molecular Adsorbent Recirculating System);
* Modified ultrafiltration during surgery.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theophile Gaillot, MD
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric intensive care - Centre mère enfants
Sainte-Foy, , Canada
Pediatric intensive care -
Sherbrooke, , Canada
Angers University Hospital
Angers, , France
Besançon University Hospital
Besançon, , France
Pediatry - Bordeaux University Hospital
Bordeaux, , France
Reanimation pediatric - Morvan Hospital
Brest, , France
Pediatry - Cote De Nacre University Hospital
Caen, , France
Pediatric nephrology - Hôpital Couple-enfants
Grenoble, , France
Bicêtre University Hospital
Le Kremlin-Bicêtre, , France
Pediatry - Hopital de la Mère et de l'Enfant
Limoges, , France
Anesthesy-Pediatric reanimation - Nord University Hospital
Marseille, , France
Pediatric Nephrology and dianetology - Arnaud de Villeneuve Hospital
Montpellier, , France
Pediatric reanimation - Hôpital mère-enfant
Nantes, , France
Réanimation et Surveillance - Robert Debre Hospital
Paris, , France
Pediatry - Reims University Hospital
Reims, , France
Nephrology - Hôpital des enfants
Toulouse, , France
Nephrology - Pediatric emergency - Clocheville University Hospital
Tours, , France
Pediatric reanimation - Brabois Hospital
Vandœuvre-lès-Nancy, , France
Groupe hospitalier Sud Reunion
Réunion, , Reunion
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-A00670-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.